Aura Biosciences (AURA) Non-cash Items (2020 - 2026)

Aura Biosciences has reported Non-cash Items for 7 years, with the latest figure at $19.3 million in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items rose 429.95% year-over-year to $19.3 million; the trailing twelve-month figure through Mar 2026 stood at $19.3 million (up 429.95% YoY), and the FY2025 full-year result was $1.5 million, down 81.37% from the prior year.
• Non-cash Items for Q1 2026 stood at $19.3 million, up from $1.5 million in the prior quarter.
• The five-year high for Non-cash Items was $19.3 million in Q1 2026, with the low at $1.5 million in Q4 2025.
• Historically, Non-cash Items has averaged $9.1 million across 5 years, with a median of $8.1 million in 2024.
• The largest YoY upside for Non-cash Items was 791.86% in 2023 against a maximum downside of 85.75% in 2023.
• Aura Biosciences' Non-cash Items stood at $16.2 million in 2022, then plunged by 36.11% to $10.4 million in 2023, then declined by 22.07% to $8.1 million in 2024, then plunged by 81.37% to $1.5 million in 2025, then surged by 1184.1% to $19.3 million in 2026.
• The last three Non-cash Items figures came in at $19.3 million (Q1 2026), $1.5 million (Q4 2025), and $14.6 million (Q3 2025), per Business Quant data.